Archive 2018
1 - 8of about 12 News
1 - 8of about 12 News
Group to take comprehensive range of portfolio, efficiency and structural measures
Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability
READ MORE
Third quarter of 2018
Bayer: Good performance in a challenging environment, Group outlook confirmed
READ MORE
Second quarter of 2018
Bayer completes biggest acquisition in its history
READ MORE
Following completion of the divestment of Crop Science businesses to BASF
Bayer: Conditions for beginning Monsanto integration fulfilled
READ MORE
LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit
READ MORE
Bayer closes Monsanto acquisition
READ MORE
Bayer plans closing of Monsanto acquisition on June 7
READ MORE
U. S. Department of Justice conditionally approves Bayer’s proposed acquisition of Monsanto
READ MORE
1 - 8of about 12 News
1 - 8of about 12 News